NomenclatureCD molecules 2006 — Human cell differentiation molecules
Introduction
The Human Leucocyte Differentiation Antigens Workshops (HLDA) have since 1984 provided a forum for the characterization and study of leucocyte surface molecules and antibodies against them (Bernard et al., 1984, Reinherz et al., 1985, McMichael et al., 1987, Knapp et al., 1989, Schlossman et al., 1995, Kishimoto et al., 1997, Mason et al., 2002, Zola et al., 2005). HLDA devised the CD nomenclature, which is sanctioned by the IUIS/WHO Nomenclature Committee (Boumsell, 1996, Zola et al., 2003). The HLDA Council reviewed and modified the objectives of HLDA in 2004, and changed the name of the organization to Human Cell Differentiation Molecules (HCDM) to reflect the broader objectives (Zola et al., 2005). Workshop studies under the HCDM banner proceeded during 2005 and early 2006, culminating in a meeting in May 2006.
The aims of this Workshop were defined more narrowly than previous HLDA Workshops, in part because of the short interval between the 8th HLDA and the first HCDM Workshop. Studies were not planned for multiple leucocyte lineages. The aims are summarized as follows:
- •
Clarify and bring up to date earlier provisional (CDw) designations.
- •
Fill in some of the CD numbers that had previously been reserved for members of molecule families such as chemokine receptors.
- •
Allocate CD numbers to new antibodies and new molecules where adequate data was submitted.
- •
Initiate multi-laboratory studies on important differentiation markers, irrespective of their cellular location. HCDM Council has previously decided that intracellular molecules that are useful markers of differentiation should be studied by the Workshops, although only surface membrane molecules will be given CD numbers (Zola et al., 2005). Studies on FOXP3 and Zap-70 were planned, because in each case there is an important application but there are disagreements on the best reagents or protocols. A specific question that merits analysis is the potential cross-reactivity of some of the Zap-70 reagents. We did not get enough Zap-70 reagents to do a worthwhile study, and the FOXP3 results were limited by the paucity of antibodies submitted.
Section snippets
Methods, results and discussion
Table 1 lists the existing CDw molecules which were re-classified as CD by the HCDM Council. Table 2 lists new CD assignments. These assignments were based on the Council's current rules for assigning a CD number, viz:
- •
at least one Workshop — characterised antibody and good molecular data
- •
the antigen is expressed on the surface of cells involved in immune reactions
- •
the antibodies react with primary cells (not just transfectants or recombinant protein)
- •
the antibody is available.
CD194 had previously
References (21)
Cell-surface IL-7 receptor expression facilitates the purification of FOXP3+ regulatory T cells
Trends Immunol.
(2006)- et al.
The receptor tyrosine kinase p185HER2 is expressed on a subset of B-lymphoid blasts from patients with acute lymphoblastic leukemia and chronic myelogenous leukemia
Blood
(1995) - et al.
Restricted expression of p55 interleukin 2 receptor (CD25) on normal T cells
Clin. Immunol. Immunopathol.
(1990) - et al.
CD molecules 2005: human cell differentiation molecules
Blood
(2005) - Battula, V.L., Bareiss, P.M., Treml, S., Conrad, S., Albert, I., Hojak, S., Abele, H., Schewe, B., Just, L., Skutella,...
The international workshops and conferences on human leukocyte differentiation antigens
Tissue Antigens
(1996)- Bühring, H.J., Battula, V.L., Treml, S., Schewe, B., Kanz, L., Vogel, W., in press. Novel markers for the prospective...
- et al.
Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells
Diabetes
(2006)
Cited by (109)
An autonomous microchip for real-time, label-free immune cell analysis
2023, Biosensors and BioelectronicsSingle nucleotide polymorphism patterns associated with a cancer resistant phenotype
2022, Experimental and Molecular PathologyCitation Excerpt :Several immune specific cell surface protein markers (cluster of differentiation markers (CD)) had unique WSB SNPs (Cd14,Cd151, Cd177, Cd1d2, Cd200r1, Cd200r2, Cd200r3, Cd200r4, Cd22, Cd244a, Cd248, Cd27, Cd274, Cd300a, Cd300c, Cd300e, Cd300lb, Cd300lf, Cd300lg, Cd320, Cd36, Cd4, Cd44, Cd55, Cd55b, Cd7, Cd72, Cd79b, Cd96, Cdc14b, Cdc42bpg, Cdc45 Cdc6, Cdca2, Cdca8, Cdh1). Expression of these proteins can enhance motility, invasion, and metastasis of cancer cells (Martin et al., 2020; Zola et al., 2007). WSB unique SNPs were found in metabolic and membrane function genes, and alterations in these functions are hallmarks of cancer (Hanahan and Weinberg, 2011).
Cold exposure aggravates pulmonary arterial hypertension through increased miR-146a-5p, miR-155-5p and cytokines TNF-α, IL-1β, and IL-6
2021, Life SciencesCitation Excerpt :Each RT-reaction used 1.5 μL from the 14 μL eluted RNA using the TaqMan MicroRNA Reverse Transcription Kit (Applied Biosystems; CA, USA). The mRNA expressions of Bmpr2, Smad5, Tgfbr2, Smad3, Cd68 and Cd163 (as surrogate for macrophage infiltration) [24,25], were determined using two-step RT-qPCR with random hexamers in combination with TaqMan probes from the Universal probe library (Roche; Basel, Switzerland) (see Table 1). Five hundred nanograms of extracted RNA were used for cDNA synthesis using QuantiNova Reverse Transcription Kit (Qiagen; Hilden, Germany).
THE EFFECTS OF ETANERCEPT AND CABERGOLINE ON ENDOMETRIOTIC IMPLANTS, UTERUS AND OVARIES IN RAT ENDOMETRIOSIS MODEL
2021, Journal of Reproductive Immunology